Dysport in Hallux Abducto Valgus (HAV) Phase IIa

Completed · Phase 2 · Has a placebo group

Conditions studied: Hallux Abducto Valgus

In brief

The purpose of this study is to investigate the efficacy and safety of treatment with multiple doses of Dysport in adults suffering from clinically significant pain associated with HAV who have not undergone surgery for their condition.

Key facts

Study ID
NCT03569098
Run by
Ipsen
People needed
186
Starts
2018-06-19
Expected to finish
2020-05-22
Last updated by the study team
2021-07-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.